GlassScriptPhysician profile
Jeffrey Thomas Prem
NPI 1235110693
$37,026.20
in general payments reported to CMS, 2019-2025
21 companies · $7,753 in 2025
The $7,753 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,989 · 2020: $866 · 2021: $1,259 · 2022: $5,006 · 2023: $6,473 · 2024: $9,680 · 2025: $7,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $3,420 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $2,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,975.00 |
| Travel and Lodging | $3,419.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $2,510.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29,036.59 | 2019-2025 | General - Therapies, Varithena Administration Pack, Eluvia |
| Penumbra, INC. | $3,144.38 | 2024 | Indigo System |
| W. L. Gore & Associates, INC. | $2,745.82 | 2019-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Inari Medical, INC. | $763.57 | 2019-2021 | |
| Artivion, INC. | $583.60 | 2019 | |
| Endologix LLC | $144.93 | 2024 | Endocross Device, Torus Stent Graft System |
| Cordis US Corp. | $124.58 | 2021-2024 | Mynx Control, S.M.A.R.T., Angioguard |
| Medtronic Vascular, INC. | $121.41 | 2019 | |
| Ethicon US, LLC | $49.51 | 2022 | |
| Silk Road Medical, INC. | $47.93 | 2019-2022 | |
| Surmodics, INC. | $45.32 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Vasorum USA INC. | $44.85 | 2022 | |
| Stryker Corporation | $37.93 | 2025 | Flowtriever |
| Dilon Technologies, INC. | $35.79 | 2024-2025 | Hemoblast Bellows |
| Angiodynamics, INC. | $18.00 | 2023 | Venacure 1470 Pro |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $15.53 | 2023 | Palindrome |
| Cardinal Health 200 LLC | $14.65 | 2021 | |
| Biocompatibles, INC. | $14.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.56 | 2019 | |
| Ekos Corporation | $12.24 | 2019 | |
| Chiesi USA, INC. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Prem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.